Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > Meeting Highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) meeting 11-14 April 2023
Meeting-highlights-from-the-Pharmacovigilance-Risk-Assessment-Committee-PRAC-11-14-April-2023-1Download
Ryan McArthur 21 April 2023 All news
  • ← Comittee for Medicinal Products for Human use : Minutes for the meeting on 23-26 January 2023
  • data.ansm: an online platform to find out more about adverse drug reactions and product shortages →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • FAQ for the webinar on the new European legislation on clinical trials for medicinal products
  • EMA: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 – 12 May 2023
  • EMA – Annual Report 2022
Copyright © 2018 - Pharmya - Legal terms - Quality Policy